MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$31,091K
Cash and cash
equivalents
$18,618K
Accounts receivable
$2,042K
Prepaid expenses and
other current assets
$1,570K
Total current assets
$53,321K
Operating lease
right-of-use asset
$4,318K
Property and equipment,
net
$736K
Other assets
$246K
Total assets
$58,621K
Total liabilities and
stockholders' equity
$58,621K
Total stockholders'
equity
$41,512K
Total liabilities
$17,109K
Total stockholders'
equity attributable to...
$33,010K
Non-controlling interest
$8,502K
Total current
liabilities
$12,669K
Operating lease
liability, less current...
$2,732K
Long-term deferred
revenue
$1,708K
Accumulated deficit
-$132,580K
Additional paid-in capital
$165,578K
Current portion of
deferred revenue
$6,831K
Accrued expenses and
other current...
$3,943K
Current portion of
operating lease liability
$1,586K
Accounts payable
$309K
Common stock,
value-Common Class A
$9K
Common stock,
value-Common Class B
$2K
Accumulated other
comprehensive gain
$1K
Back
Back
Balance Sheet
source: myfinsight.com
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI)